Efficacy and Safety of Catheter‐Based Renal Denervation for Patients With Hypertension: A Systematic Review and Meta‐Analysis
The Journal of Clinical Hypertension · 2025
DOI: 10.1111/jch.70080 ↗At a glance
Systematische Übersicht in The Journal of Clinical Hypertension, 2025. Written by Xiao Chen and 5 co-authors. Institution: Department of Neurosurgery, Suzhou Ninth People's Hospital, Suzhou, Jiangsu, China. Major MEDLINE topics: Hypertension, Kidney, Sympathectomy, Catheter Ablation. Cited 3 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Suzhou Ninth People's Hospital Research Fund Project.
Abstract (original language)
This meta‐analysis evaluates the efficacy and safety of renal denervation (RDN) for patients with hypertension. PubMed, EMBASE, the Cochrane Library, and ClinicalTrials.gov were systematically searched to identify relevant studies published before December 31, 2024. Review Manager 5.3 software was used to assess the results of the meta‐analyses and the risk of bias plot. We pooled 2208 participants from 13 studies. The RDN was superior to the sham surgery group in the change in 24 h ambulatory systolic blood pressure (ASBP) and the change in 24 h ambulatory diastolic blood pressure (ADBP) (MD: −4.55 mmHg, 95% CI: −5.65 to −3.44; MD: −2.37 mmHg, 95% CI: −3.06 to −1.68, respectively). For the change in daytime ASBP and ADBP, significant differences were found between the RDN group and the sham group (MD: −6.21 mmHg, 95% CI: −7.61 to −4.80; MD: −2.96, 95% CI: −3.85 to −2.07). Compared to the sham surgery group, the RDN group showed better results in the change in night‐time ASBP and ADBP (MD: −4.67 mmHg, 95% CI: −6.32 to −3.03; MD: −2.28 mmHg, 95% CI: −3.33 to −1.24). No significant differences were found between the RDN group and the sham group in terms of adverse events (AEs) and serious adverse events (SAEs) ( p = 0.39 and 0.07). Subgroup analyses showed that RDN remains effective at long‐term follow‐up, and both ultrasound and radiofrequency RDN were effective. Current evidence shows that RDN is an effective treatment for patients with hypertension and does not increase the risk of AEs and SAEs.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Neurosurgery, Suzhou Ninth People's Hospital, Suzhou, Jiangsu, China.
- Department of Neurology, Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China.
- Department of Emergency, Suzhou Ninth People's Hospital, Suzhou, Jiangsu, China.
ORCID profiles: Yanfang Zhang
Funding
- Suzhou Ninth People's Hospital Research Fund Project
Cite
APA
Chen, X., Meng, J., Zhou, Q., Ni, Y., Zuo, C., & Zhang, Y. (2025). Efficacy and Safety of Catheter‐Based Renal Denervation for Patients With Hypertension: A Systematic Review and Meta‐Analysis. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.70080
Vancouver
Chen X, Meng J, Zhou Q, Ni Y, Zuo C, Zhang Y. Efficacy and Safety of Catheter‐Based Renal Denervation for Patients With Hypertension: A Systematic Review and Meta‐Analysis. The Journal of Clinical Hypertension. 2025. doi:10.1111/jch.70080
BibTeX
@article{Chen2025,
author = {Chen, Xiao and Meng, Jie and Zhou, Qiufeng and Ni, Yuehua and Zuo, Changyang and Zhang, Yanfang},
title = {Efficacy and Safety of Catheter‐Based Renal Denervation for Patients With Hypertension: A Systematic Review and Meta‐Analysis},
journal = {The Journal of Clinical Hypertension},
year = {2025},
doi = {10.1111/jch.70080}
}
EUVIMED